Correction to: Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

Signal Transduct Target Ther. 2021 Apr 19;6(1):161. doi: 10.1038/s41392-021-00540-4.

¹ HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150080, China.
² Department of Infectious Diseases, Heilongjiang Provincial Hospital, Harbin Institute of Technology, Harbin, 150030, China.
³ Harbin Blood Center, Harbin, 150056, China.
⁴ Centre for Reproductive Medicine, Heilongjiang Provincial Hospital, Harbin Institute of Technology, Harbin, 150030, China.
⁵ Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150040, China.
⁶ HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150080, China. [email protected].

^# Contributed equally.

No abstract available

Publication types